MREO

MEREO BIOPHARMA GROUP PLC

MREO·589492107·US·ADR·Healthcare - Biotechnology-13D/G

MREO (MEREO BIOPHARMA GROUP PLC) is held by 32 institutional investors as of Q1 2026. Largest holders: BANK OF AMERICA CORP /DE/ ($2.7M), MILLENNIUM MANAGEMENT LLC ($1.2M), UBS Group AG ($491,742). Net institutional sentiment: Mixed.

32
Holders
Avg rating(9 Elite)
$5.4M
Total Value
37% (43)
Fund Consensus
13 buying - 22 selling
MREOSmart Money Verdict
View all
Held by 32 funds
9 elite
Who's Trading
ActivistECEcoR1 Capital, LLC8.4%May 15, 2026
ActivistBANK OF AMERICA CORP /DE/BANK OF AMERICA CORP /DE/5.1%May 14, 2026
ActivistJANUS HENDERSON GROUP PLCJANUS HENDERSON GROUP PLC0.0%Feb 17, 2026
ActivistNVNorthpond Ventures, LP0.0%Feb 17, 2026
ActivistFLFrazier Life Sciences Public Fund, L.P.0.0%Feb 13, 2026
Activist68683 Capital Management, LLC8.2%Jan 6, 2026
ActivistMIMangrove Partners IM, LLC4.9%Nov 14, 2025
ActivistRSRock Springs Capital Management LP4.2%May 15, 2025
ActivistADAdage Capital Management, L.P.1.1%May 12, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
8.2M(+320x)$2.7M0.0%-18.25%
42
Increased
3.6M(+4155.0%)$1.2M0.0%-27.95%
41
Decreased
1.5M(-4.4%)$491,7420.0%-80.39%
0
New
796,036$262,6920.0%-17.07%
32
New
686,987$226,7060.0%-17.07%
32
Decreased
335,827(-24.0%)$110,8230.0%-67.65%
0
Decreased
302,991(-3.1%)$99,9860.0%-89.29%
0
New
195,920$64,6540.0%-17.07%
32
Decreased
187,839(-64.2%)$61,9870.0%-85.12%
0
Decreased
139,973(-60.7%)$46,1910.0%-87.07%
0
Increased
133,379(+2.1%)$44,0150.0%-87.18%
14
Unchanged
92,534$30,5360.0%-89.24%
0
New
84,469$27,8750.0%-17.07%
27
Increased
64,064(+28.1%)$21,1410.0%-83.14%
23
Decreased
48,400(-75.1%)$15,9720.0%-79.80%
0
Unchanged
25,000$8,2500.0%-74.81%
0
Decreased
23,954(-51.9%)$7,9050.0%-8.11%
0
New
21,848$6,9040.0%-17.07%
25
Increased
19,572(+2.2%)$6,4520.0%-75.01%
11
Unchanged
18,300$6,0390.0%-64.40%
0

Showing 1-20 of 43

1 / 3

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used